Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Phase 2 and Phase 3 trial data Major clinical trials: Phase 2 (24-week trial, 2008): 203 obese participants Three dose groups: 0.25mg, 0.5mg, 1.0mg daily Placebo-controlled, randomized Primary outcome: Weight loss percentage Phase 2 results: Key findings: Dose-dependent weight loss 1mg dose: Average 23 lbs lost (starting weight ~220 lbs) Best responders: 15-20% weight loss Comparable to semaglutide 2.4mg But higher dropout due to side effects Phase 3 trials (planned but never completed): Intended for FDA approval Halted due to cardiovascular concerns Increased heart rate 5-10 bpm average Blood pressure elevation 2-5 mmHg Risk-benefit ratio questioned Development suspended 2010 Long-term data (limited): 1-year extension studies showed sustained loss Weight plateau at 6-9 months Some regain if discontinued No controlled trials beyond 1 year Safety concerns prevented longer studies Compare to semaglutide trials and tirzepatide results
The supplement contains well over 100% of the DV for vitamin B12
You do not have to have an appointment or pay a follow-up visit fee to stop by and purchase additional injections from the weight clinic receptionist
Allergic reaction: While rare, some individuals are allergic to injectable formulations or preservatives
With so many benefits, its understandable that youve been thinking about scheduling your own IV vitamins in Lafayette or even vitamin shots in Lafayette during your therapy appointment
It is an efficient method of boosting vitamin b12 levels
US$ 24.11
US$ 24.41
US$ 23.32
